Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (2018)

First Author: Connick P
Attributed to:  Medical image computing for next-generation healthcare technology funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-021944

PubMed Identifier: 30166303

Publication URI: http://europepmc.org/abstract/MED/30166303

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 8

ISSN: 20446055